Meeting
2014 ASCO Annual Meeting
Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas.
Authors
Juliana Eng
Memorial Sloan Kettering Cancer Center, New York, NY
Juliana Eng , Matthew David Hellmann , Kaitlin Woo , Camelia S. Sima , Helena Alexandra Yu , Maria E. Arcila , Marc Ladanyi , Mark G. Kris , Alexander E. Drilon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8074)
DOI
10.1200/jco.2014.32.15_suppl.8074
Abstract #
8074
Poster Bd #
255
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Migration to next-generation sequencing and the identification of RET and ROS1 rearrangements plus PTEN and MET protein expression in tumor specimens from patients with lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC 2.0).
First Author: Mark G. Kris
Poster
2014 ASCO Annual Meeting
Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers.
First Author: Alexander E. Drilon
Poster
2014 ASCO Annual Meeting
Multi-institutional multiplexed genetic analysis in lung adenocarcinoma (AC): The Lung Cancer Mutation Consortium (LCMC I) experience.
First Author: Dara Aisner
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon